Description

Tianjin Chase Sun Pharmaceutical Co.,Ltd is a Chinese pharmaceutical company engaged in the comprehensive lifecycle of drug development, from research and manufacturing to marketing, within the Chinese market. Its diverse product portfolio encompasses traditional Chinese herbal preparations, granulated medicines, synthetic drugs, and biotechnological pharmaceuticals, along with medical devices and innovative internet-based therapeutic solutions. Beyond its current offerings, the company maintains an active research and development pipeline, focusing on critical therapeutic areas. These include treatments for conditions such as sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular disorders, arthritis, ischemic stroke, Hepatitis C (HCV), general vascular diseases, psychosis, and oncological chemotherapy. Furthermore, it is developing anesthetic drugs and immunomodulatory agents. Established in 1996, Tianjin Chase Sun Pharmaceutical Co.,Ltd is headquartered in Tianjin, China.